Alpha Genesis

Alpha Genesis Inc. (AGI) operates in the biomedical research sector, specializing in the provision of specific pathogen free (SPF) nonhuman primate models. These models are crucial for a variety of contract research applications, particularly in the development of new medical treatments and vaccines. AGI serves the biomedical research community, including pharmaceutical companies, academic institutions, and government agencies. The company offers enriched housing facilities for nonhuman primates, both in CDC quarantine and non-quarantine settings, on a cost-effective per diem basis. AGI's business model revolves around providing high-quality primate models and housing solutions, ensuring the highest standards of care and ethical treatment. Revenue is generated through the leasing of primate models and housing facilities, as well as through contract research services. The company's AAALAC accredited facilities and highly qualified staff underscore its commitment to excellence in research and animal care.

Keywords: nonhuman primate models, biomedical research, SPF primates, contract research, enriched housing, CDC quarantine, pharmaceutical research, academic institutions, government agencies, AAALAC accredited.